Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S OSBORN

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
Cardiology|May 27, 2010
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategiesMegan B Smith, Nedra Christensen, Shiquan Wang, et al.
Heart Rhythm|November 30, 2014
Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leadsSeth H Sheldon, T Jared Bunch, Gregory A Cogert, et al.
Human Molecular Genetics|September 15, 2018
Bi-allelic mutations in MYL1 cause a severe congenital myopathyGianina Ravenscroft, Irina T Zaharieva, Carlo A Bortolotti, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
Nature Genetics|January 25, 2011
Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndromeCaroline Rooryck, Anna Diaz-Font, Daniel P S Osborn, et al.
Human Molecular Genetics|February 5, 2019
Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24Carola Hedberg-Oldfors, Alexandra Abramsson, Daniel P S Osborn, et al.
American Journal of Human Genetics|February 14, 2017
Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and DystroglycanopathyDaniel P S Osborn, Heather L Pond, Neda Mazaheri, et al.
Nature Communications|October 23, 2019
Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegiaMatias Wagner, Daniel P S Osborn, Ina Gehweiler, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
Cardiology|May 27, 2010
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategiesMegan B Smith, Nedra Christensen, Shiquan Wang, et al.
Heart Rhythm|November 30, 2014
Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leadsSeth H Sheldon, T Jared Bunch, Gregory A Cogert, et al.
Human Molecular Genetics|September 15, 2018
Bi-allelic mutations in MYL1 cause a severe congenital myopathyGianina Ravenscroft, Irina T Zaharieva, Carlo A Bortolotti, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
Nature Genetics|January 25, 2011
Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndromeCaroline Rooryck, Anna Diaz-Font, Daniel P S Osborn, et al.
Human Molecular Genetics|February 5, 2019
Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24Carola Hedberg-Oldfors, Alexandra Abramsson, Daniel P S Osborn, et al.
American Journal of Human Genetics|February 14, 2017
Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and DystroglycanopathyDaniel P S Osborn, Heather L Pond, Neda Mazaheri, et al.
Nature Communications|October 23, 2019
Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegiaMatias Wagner, Daniel P S Osborn, Ina Gehweiler, et al.
Pageof 11